mRNA vaccines administered with an extended interval between doses elicit strong SARS-CoV-2 antibody responses after two doses

Findings from a real-world vaccination study composed of seniors residing in long-term care facilities were recently released in preprint, therefore not yet peer-reviewed, on behalf of investigators from the CITF-funded study UNCoVER (including Dr. Donald Vinh, Research Institute of the McGill University Health Centre (RI-MUHC) and Dr. Marc-André Langlois, University of Ottawa) and the CITF Secretariat (Dr. Bruce Mazer, Associate Director, Strategy, affiliated with the MUHC).